Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
10
11
12
13
14
15
16
19
11:00 AM - Charmalot 2025
20
21
22
23
24
25
26
27
29
1
2
3
4
5
Oracle Health and Life Sciences Summit 2025
2025-09-09 - 2025-09-11    
12:00 am
The largest gathering of Oracle Health (Formerly Cerner) users. It seems like Oracle Health has learned that it’s not enough for healthcare users to be [...]
MEDITECH Live 2025
2025-09-17 - 2025-09-19    
8:00 am - 4:30 pm
This is the MEDITECH user conference hosted at the amazing MEDITECH conference venue in Foxborough (just outside Boston). We’ll be covering all of the latest [...]
AI Leadership Strategy Summit
2025-09-18 - 2025-09-19    
12:00 am
AI is reshaping healthcare, but for executive leaders, adoption is only part of the equation. Success also requires making informed investments, establishing strong governance, and [...]
OMD Educates: Digital Health Conference 2025
2025-09-18 - 2025-09-19    
7:00 am - 5:00 pm
Why Attend? This is a one-of-a-kind opportunity to get tips from experts and colleagues on how to use your EMR and other innovative health technology [...]
Charmalot 2025
2025-09-19 - 2025-09-21    
11:00 am - 9:00 pm
This is the CharmHealth annual user conference which also includes the CharmHealth Innovation Challenge. We enjoyed the event last year and we’re excited to be [...]
Civitas 2025 Annual Conference
2025-09-28 - 2025-09-30    
8:00 am
Civitas Networks for Health 2025 Annual Conference: From Data to Doing Civitas’ Annual Conference convenes hundreds of industry leaders, decision-makers, and innovators to explore interoperability, [...]
TigerConnect + eVideon Unite Healthcare Communications
2025-09-30    
10:00 am
TigerConnect’s acquisition of eVideon represents a significant step forward in our mission to unify healthcare communications. By combining smart room technology with advanced clinical collaboration [...]
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
Events on 2025-09-09
Events on 2025-09-17
MEDITECH Live 2025
17 Sep 25
MA
Events on 2025-09-18
OMD Educates: Digital Health Conference 2025
18 Sep 25
Toronto Congress Centre
Events on 2025-09-19
Charmalot 2025
19 Sep 25
CA
Events on 2025-09-28
Civitas 2025 Annual Conference
28 Sep 25
California
Events on 2025-10-05
Articles

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

amyotrophic lateral scelrosis

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

Amyotrophic lateral sclerosis (ALS) belongs to a group of neurological disease. Otherwise called motor neuron diseases, they influence the engine elements of voluntary muscles in the body. Factors, for example, an expansion in the occurrence rate of ALS, grow in the awareness about the ailment among patients, and ascend in the geriatric populace is relied upon to help the development of the amyotrophic lateral sclerosis market. Other factors including the tendency towards the stationary way of life are driving the market development and expanding the danger of getting attacked by ALS.

Furthermore, the expanding geriatric populace substantiates market development, making interest in symptomatic and focused on treatment alternatives. However, the staggering expense of the treatment of ALS may impede market development over the figure time frame.

The Amyotrophic lateral sclerosis market is growing at 7.89 % CAGR and is expected to reach the valuation of USD 841.6 million by the year 2023.

Major players

Mylan N.V. (U.S.), Covis Pharma (Switzerland), Ionis Pharmaceutical (U.S.), ITF Pharma (U.S.), Ascend Pharmaceuticals LLC (U.S.), Apotex Inc. (Canada), Sun Pharmaceutical (India), Mitsubishi Tanabe Pharma America (U.S.), Biogen (U.S.), Sanofi (France), among others are some of the major players in the Global amyotrophic lateral sclerosis market.

The Global amyotrophic lateral sclerosis market has been classified on the basis of its treatment, type, end-user, and regional demand. Based on its type, the market is classified into familial ALS and sporadic. Based on its treatment, the market has been segmented into physical therapy, speech therapy, medication, respiratory therapy, and others. By its end-user, the ALS market has been segmented into research & academic institutes, specialty centers, hospitals, and others.

Source inforgrowth.com/report/1850367/amyotrophic-lateral-sclerosis-market

About InForGrowth

At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.